Publications


Competition and Risk


Doni Bloomfield

Antitrust Law Journal, forthcoming, 2024


Extending Drug Monopolies by Patenting Safe Drug Use


Doni Bloomfield, Bryan S. Walsh, Aaron S. Kesselheim

JAMA Internal Medicine, vol. 182(3), 2022, pp. 245-246


Characteristics of Clinical Trials Evaluating Biosimilars in the Treatment of Cancer: A Systematic Review and Meta-Analysis.


Doni Bloomfield, Elvira D’Andrea, Sarosh Nagar, Aaron S. Kesselheim

JAMA Oncology, vol. 8(4), 2022, pp. 537-545


Improving the Quality of US Drug Patents Through International Awareness


Doni Bloomfield, Zhigang Lu, Aaron S. Kesselheim

British Medical Journal, vol. 377, 2022


Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986-2020.


William B. Feldman, Doni Bloomfield, Reed F. Beall, Aaron S. Kesselheim

Health Affairs, vol. 41(6), 2022


A Court Decision on Skinny Labeling: Another Challenge for Less Expensive Drugs


Bryan S. Walsh, Doni Bloomfield, Aaron S. Kesselheim

JAMA, vol. 326(14), 2021, pp. 1371-1372


Consumers and Citizens: The Future of the Consumer Welfare Standard in Global Merger Review


Jesse Solomon, Gregory S. Morrison, Doni Bloomfield

Antitrust Law Journal, vol. 84, 2021, pp. 701-743

Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in